Technology Trends 2027: What AI, Robotics and Energy Storage Mean for the Enterprise

Jeet Poptani, Chief Transformation Officer at AumentoAI, maps the technologies moving from lab to balance sheet in 2027 — what they are, what capital is already betting on them, and what it will actually take to run them inside a large enterprise.

Every year produces a “trends” list. Most of them are recycled. 2027 is different, and the difference shows up in the money before it shows up in the headlines: global venture capital hit an all-time-high $300 billion in a single quarter in early 2026, and four out of every five of those dollars went to artificial intelligence and the physical systems it now controls. That is not sentiment. That is capital markets pricing in a specific bet — that the next three years move AI out of the chat window and into the factory floor, the power grid, the operating theatre, and low Earth orbit. This piece walks through the technologies behind that bet: what changed, what it costs, what it's worth, and — because this is written for people who have to actually deploy this, not just admire it — the strategy to get value from it and the technical capability it requires underneath.

The investment signal: capital has already decided where 2027 goes

Before the technology, the money. In Q1 2026, investors deployed $300 billion into roughly 6,000 startups worldwide — a 150% jump quarter-on-quarter and year-on-year, and the largest single quarter of venture investment ever recorded. AI captured $242 billion of it, or 80% of the total, up from 55% a year earlier. Four rounds — OpenAI ($122 billion), Anthropic ($30 billion), xAI ($20 billion) and Waymo ($16 billion) — accounted for 65% of everything invested globally in that quarter. The United States took 83% of the total.

That concentration matters strategically in two ways. First, it means the infrastructure layer of AI — compute, foundation models, autonomy stacks — is now capitalised at a scale that makes it a fixed feature of the competitive landscape, not a bet that might not pay off. Second, it means capital is now flowing visibly beyond software into what the venture market calls “physical AI”: robots, autonomous vehicles, aerospace and defense-tech, energy systems. That shift — money leaving the browser and entering the physical world — is the organising idea behind everything that follows in this piece.

The strategy to achieve results

• Treat 2026-2027 capital flows as a leading indicator for your own roadmap, not background news. When 80% of global venture funding follows a category, the vendors, talent market and standards in that category mature faster than your internal planning cycle assumes. Budget accordingly.

• Separate “AI as a feature” from “AI as an operating model” in your own investment case. The mega-rounds above are buying foundational capability, not point solutions — the equivalent enterprise move is funding a platform and a governance model, not a list of unconnected pilots.

• Watch where physical capital is moving, not just software capital, because that is the earliest signal of which industries are about to face genuine cost and labour disruption from automation.

Artificial intelligence: from generating text to running processes

The AI story in 2027 is not “better chatbots.” It is AI moving into three places it wasn't a year ago: writing and shipping its own code, running as autonomous agents inside business processes, and — critically — becoming interpretable enough that regulators and boards can actually audit what it is doing.

Generative coding has moved from autocomplete to end-to-end software delivery: tools that write, test and deploy code with a human reviewing outcomes rather than typing syntax. Hyperscale AI data centers — massive, synchronised clusters of specialised chips — are the physical precondition for all of this, and they are now themselves one of MIT Technology Review's ten breakthrough technologies of the year, reflecting how much of the AI story has quietly become a power and infrastructure story. And mechanistic interpretability — techniques for looking inside a large language model to see what it is actually computing, not just what it outputs — has gone from academic curiosity to commercial necessity, with Anthropic's own research reportedly identifying structured internal “concept spaces” that models use to reason, a meaningful step toward being able to explain, audit and certify what an AI agent is doing before it is trusted with a decision.

Enterprise adoption is tracking accordingly. Gartner has warned that more than 40% of agentic AI projects will be cancelled before the end of 2027 — not because the technology fails, but because the business case, integration, and governance around it were never built properly in the first place. That is the single most important sentence in this section for anyone deploying AI inside a large organisation.

The strategy to achieve results

• Fund the governance layer at the same time as the first agent, not after the fifth. The projects Gartner expects to fail are overwhelmingly the ones where a pilot proved technical feasibility and nobody had built the decision-rights, audit trail, or escalation model to scale it.

• Pick interpretability-capable platforms deliberately. As mechanistic interpretability moves from research to product, the vendors who can show you why their model reached a conclusion — not just that it did — will be the ones that pass procurement, audit and (in the EU) AI Act scrutiny first.

• Model the compute and token economics of agentic AI into the business case up front. Hyperscale infrastructure has a real, rising cost curve; a use case that looks free in a demo is not free at production volume.

The technical know-how this actually requires

• Agent orchestration and multi-agent system design — composing narrow, auditable agents into a workflow, rather than deploying one large autonomous system with unclear boundaries.

• Prompt, retrieval and grounding engineering against your own enterprise data — the gap between demo and production is still, overwhelmingly, a data readiness problem.

• Working fluency in interpretability tooling as it becomes a genuine procurement and compliance requirement, not just a research interest.

• Compute capacity planning — understanding token economics, GPU/accelerator allocation, and the hyperscaler relationship well enough to forecast cost at scale.

Robotics and physical AI: intelligence gets a body

If 2023–2025 was the AI-writes-text era, 2026–2027 is the AI-controls-a-body era. Robotics startups have already raised $18.8 billion globally through mid-2026 — more than the full-year record set in 2021 ($14.1 billion) and more than all of 2025 ($15 billion), with six months of the year still to go. The broader “physical AI” category — robotics, autonomy, aerospace and defense-tech together — raised $47.4 billion in the first half of 2026 alone, nearly double the $26.4 billion raised in the same period a year earlier.

The headline deals tell the story of where the money believes the value is: Waymo raised $16 billion at a $126 billion valuation; Anduril raised $5 billion at $61 billion; humanoid-robot maker Neura Robotics raised $1.4 billion, as did multi-robot software platform Skild AI at a valuation north of $14 billion; autonomous maritime defense company Saronic raised $1.75 billion. The pattern across nearly every one of these deals is the same: investors are pricing robots as software-defined platforms running on foundation models, not as one-off hardware projects — which is exactly the shift that makes this a genuinely new category rather than a rerun of the last robotics cycle.

The strategy to achieve results

• Distinguish “automation” from “physical AI” in your own planning. Classic industrial automation replaces a fixed task; embodied AI systems generalise across tasks using the same foundation-model approach that made large language models useful — which changes the make-or-buy calculus for warehouse, field-service and manufacturing automation entirely.

• Pilot against your highest-cost, highest-volume physical task first, not the most visually impressive one — the economics of physical AI are still driven by utilisation, not novelty.

• Build safety and liability frameworks before scale, not after an incident. A physical agent that fails has consequences a software agent does not, and insurers, regulators and boards will all expect a documented model for this before broad deployment.

The technical know-how this actually requires

• Sensor fusion and real-time perception — combining vision, LiDAR and force feedback into decisions made in milliseconds, not seconds.

• Foundation-model grounding for physical control — the same “which SAP skill do I assemble” logic from enterprise AI now applies to which robotic skill library you compose rather than build from scratch.

• Fleet and edge infrastructure management — most physical AI runs partly on-device for latency reasons, which means a genuinely new edge-computing competency alongside the cloud one your IT organisation already has.

• Physical safety certification and human-robot interaction design — a discipline most enterprise IT functions have never needed until now.

Energy storage and next-generation nuclear: the grid that has to carry all of this

Every one of the technologies in this piece — the data centers, the robots, the agents — needs power, and 2026 is the year the energy story stopped being about generation alone and became, just as urgently, about storage and reliability.

Sodium-ion batteries are MIT Technology Review's top breakthrough technology of 2026, and for a specific reason: sodium is cheap and abundant everywhere, unlike lithium, which removes a real supply-chain vulnerability. Chinese manufacturers CATL and BYD are already scaling commercial production — CATL's Naxtra line launched in 2025, and BYD is building large-scale manufacturing capacity. Today's cells aren't yet meaningfully cheaper than lithium-ion, but costs are expected to fall fast as manufacturing scales, and the technology's real thermal stability and cycle-life advantages make it particularly suited to grid-scale storage — the single biggest bottleneck standing between intermittent solar and wind generation and a genuinely reliable clean grid. Peak Energy is already deploying grid-scale sodium-ion systems in the US.

Alongside storage, next-generation nuclear is moving from paper design to steel: small modular reactors (SMRs) that are a fraction of the size of legacy plants, built on assembly lines rather than as bespoke construction projects, using safer TRISO fuel (uranium kernels encased in carbon and ceramic that withstand extreme heat) and alternative coolants like molten salt that run hotter and at lower pressure than traditional water-cooled designs. China's Linglong One — the world's first land-based commercial SMR — is set to come online by the end of 2026; Kairos Power's Hermes 2 demonstration reactor is approved for construction with operation targeted for 2030; BWXT is developing mobile reactors for defense applications.

The strategy to achieve results

• Model power availability as a genuine constraint on your AI roadmap, not a utilities-department problem. The compute ambitions in the AI section above are directly gated by how much reliable power an enterprise or its cloud provider can actually secure.

• Evaluate grid-storage and on-site generation partnerships now, while capacity is being allocated, rather than after your AI or automation programme has already outgrown available power.

• Treat sodium-ion's cost curve as a multi-year bet, not an immediate saving — the investment case today is supply-chain resilience and safety, with cost parity following as manufacturing scales.

The technical know-how this actually requires

• Grid-scale battery chemistry and integration literacy — enough to evaluate vendor claims on cycle life, thermal safety and total cost of ownership rather than taking them at face value.

• Power purchase agreement and on-site generation structuring — increasingly a core competency for any enterprise running large compute or automation estates, not just utilities specialists.

• Regulatory and siting knowledge for SMRs and battery storage, which vary sharply by jurisdiction and are moving targets through 2027.

Quantum computing: from theory to a funded roadmap

Quantum computing crossed a real threshold in 2026: IBM committed more than $10 billion over five years to deliver Quantum Starling — what it calls the world's first large-scale, fault-tolerant quantum computer — by 2029, capable of 20,000 times more operations than today's systems. Google and Microsoft have made parallel claims around error-correction milestones and topological qubit approaches over the same period. The significance isn't that quantum computers are useful today for mainstream enterprise workloads — they largely aren't yet — it's that the roadmap to fault tolerance now has a funded, dated commitment behind it from a company with every incentive not to overpromise to its own shareholders.

The strategy to achieve results

• Start a quantum literacy programme now, not a quantum deployment programme. The organisations that extract value in the early 2030s will be the ones whose technical leadership already understands the use cases (materials science, financial risk modelling, drug discovery, logistics optimisation) before the hardware is generally available.

• Track your industry's specific quantum-vulnerable cryptography exposure. Post-quantum cryptography migration is a multi-year infrastructure project in its own right, and 2027 is the year to be planning it, well ahead of any working quantum computer that could threaten current encryption.

The technical know-how this actually requires

• Post-quantum cryptography migration planning — inventorying where your organisation relies on encryption that a future fault-tolerant quantum computer could break.

• Enough quantum algorithm literacy to evaluate genuine use cases (optimisation, simulation) versus vendor hype, which remains rampant in this category.

Biotech and the genetic frontier: personalised medicine gets specific

Three of MIT Technology Review's ten 2026 breakthrough technologies sit in genetics and biotech, and together they describe a shift from population-level medicine to individually engineered treatment. A base-edited treatment personalised for a single infant with a rare, otherwise-fatal genetic condition has moved from theoretical to clinically demonstrated, with further trials now underway — a milestone in using precision gene-editing tools clinically at the individual-patient level rather than only in broad population trials. Separately, researchers are mining genetic material from extinct species to inform new treatments and conservation science (“gene resurrection”), and embryo screening technology has advanced to the point of assessing disease risk and, more controversially, predicting complex traits including cognitive ability — a capability that has drawn serious ethical scrutiny from geneticists and bioethicists over its accuracy claims and its social implications, and is regulated very differently across jurisdictions.

For enterprises in pharma manufacturing, healthcare and life sciences specifically, this is directly strategic rather than merely interesting: personalised and small-batch genetic therapies require fundamentally different manufacturing, supply chain and regulatory models than the blockbuster-drug manufacturing most pharma ERP and MES systems were designed around.

The strategy to achieve results

• Pharma and life-sciences manufacturers should audit whether their current ERP/MES architecture can handle small-batch, patient-specific production runs — the operating model for personalised gene therapy is closer to high-mix, low-volume manufacturing than the high-volume model most systems were built for.

• Build the regulatory and ethical review capability alongside the R&D capability, not after a product is close to launch — embryo-screening-adjacent and gene-editing technologies are drawing regulatory attention that varies significantly by country.

The technical know-how this actually requires

• Cold-chain and patient-specific batch traceability at a manufacturing systems level — a materially different requirement from standard pharmaceutical ERP configuration.

• Regulatory intelligence spanning multiple jurisdictions, since gene-editing and embryo-screening rules are both fast-moving and inconsistent globally.

Space technology: low Earth orbit goes commercial

The International Space Station deorbits in 2031, and NASA has already committed over $500 million to seed private replacements — which is why commercial space stations made MIT's 2026 breakthrough list and why 2027 is the year the first of them actually flies. Vast Space's Haven-1 is targeting an early-2027 launch (delayed from an initial May 2026 date); Axiom Space's Axiom Station and Voyager Space's Starlab are targeting 2028; Blue Origin's Orbital Reef is targeting 2030. Early missions will host four-person crews for roughly ten-day stays, running research including plant cultivation and pharmaceutical manufacturing in microgravity — a genuine new category of industrial R&D infrastructure, even if today's ticket prices (tens of millions of dollars) keep it well out of reach of most enterprises for now.

The strategy to achieve results

• Life-sciences and materials-science organisations should track microgravity R&D access as an emerging, if currently expensive, research channel — the pharmaceutical manufacturing experiments already running on these platforms are a preview of a genuine future production environment, not a novelty.

• Treat this as a five-to-ten-year horizon technology for direct enterprise use, while recognising that the underlying launch-cost and reliability trends (driven by SpaceX's scale, among others) have consistently outpaced conservative forecasts over the last decade.

Brain-computer interfaces: the quietest breakthrough with the loudest implications

Progress here is real but earlier-stage than the categories above. Neuralink has continued expanding its human trials through 2026, and has moved toward regulatory approval for a vision-restoration application (“Blindsight”) alongside its original motor-control work; Synchron continues to advance its less invasive, blood-vessel-delivered implant approach; Blackrock Neurotech and other established players continue parallel clinical work. None of this is enterprise-relevant in 2027 in the way AI or robotics are — but it belongs on any serious technology-trends list because the underlying signal-decoding techniques are increasingly shared with the same foundation-model approaches reshaping robotics, and the assistive and accessibility applications are moving faster than most non-specialists realise.

What this means for enterprise leaders in 2027

Pull back from the individual technologies and one pattern holds across every section above: the winners will not be the organisations that adopt the most new technology fastest. They will be the ones that build the governance, data foundation and workforce capability to absorb it responsibly — which is precisely why Gartner expects 40% of agentic AI projects to fail by the same deadline this article is named for. The 2026-2027 window is not a race to deploy; it is a race to build the operating model that makes deployment safe, auditable and reversible.

For CFOs, that means underwriting power, compute and governance costs alongside the AI or automation business case itself, not as an afterthought. For CIOs, it means treating agent orchestration, interpretability tooling, edge infrastructure and post-quantum cryptography planning as 2027 budget lines, not 2029 ones. For CEOs, it means recognising that the capital markets have already made their bet — four out of five venture dollars, record robotics funding, a ten-billion-dollar quantum roadmap — and that the strategic question is no longer whether these technologies arrive inside the enterprise, but whether your organisation's operating model is ready to receive them when they do.

AumentoAI advises CEO, CFO and CIO offices on translating emerging-technology roadmaps into funded, governed enterprise programmes — from AI and robotics investment cases to the operating model changes they require. Book a Value Advisory Session to pressure-test your 2027 technology roadmap.